New schizophrenia treatments may be effective for subgroup of patients

Mounting evidence indicates that disturbances in the brain's glutamate pathway contribute to symptoms of schizophrenia. Thus, the glutamate pathway has become the target of a number of new drug therapies. Findings suggest that at least one of these drugs may be an effective treatment for individuals in the early course of the illness.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1XZ6af5